Gevorg Grigoryan

Title: Gevorg Grigoryan: Innovator in Antigen Binding Molecules

Introduction

Gevorg Grigoryan is a notable inventor based in Arlington, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of antigen binding molecules. With a total of 5 patents to his name, Grigoryan's work is at the forefront of scientific innovation.

Latest Patents

Among his latest patents is the invention of Antigen Binding Molecules Targeting SARS-CoV-2. This patent addresses critical challenges in combating the COVID-19 pandemic. Another significant patent involves Modulators of Parathyroid Hormone Receptor (PTHR1). This invention provides synthetic parathyroid hormones (sPTHs) that can modulate the activity of the parathyroid hormone receptor, specifically PTHR1. The methods outlined in this patent offer innovative approaches to modulating PTHR activity in various cellular contexts.

Career Highlights

Gevorg Grigoryan is currently associated with Flagship Pioneering Innovations Vi, LLC. His role in this company allows him to leverage his expertise in biotechnology and contribute to groundbreaking research and development.

Collaborations

Throughout his career, Grigoryan has collaborated with esteemed colleagues, including John Ingraham and Jordi Mata-Fink. These partnerships have further enhanced his research capabilities and innovation potential.

Conclusion

Gevorg Grigoryan stands out as a prominent inventor in the biotechnology sector, with a focus on developing solutions for pressing health challenges. His contributions through patents and collaborations continue to shape the future of medical science.